Aarti Gupta is currently driven by Pharmaceuticals. The recent article tape shows 8 bullish, 1 bearish, and 1 neutral reads across 3 sources.
Updated 29 Aug 2026, 11:52 am IST · Sentiment is computed from saved analyzed news and quote snapshots.
Aarti Gupta has 11 recent analyzed stories in this hub, with a sector bias score of +44. The dominant cluster is Pharmaceuticals, and the story breadth is 8 bullish, 1 bearish, and 1 neutral reads.
The most repeated listed names are DRL, MANKIND, AARTIPHARM, BATAINDIA, BDL. These are the names drawing the most coverage; quote movement, volume, and company-specific context add further reference.
Vikas Gupta, CEO of OmniScience Capital, discusses the recent positive shift in Foreign Portfolio Investors (FPIs) towards Indian equities. With a focus on non-AI diversification and strong growth sectors, Gupta outlines a hopeful outlook for the Indian market amid global inflation pressures.
No negative stock cluster yet.
Mint · 2 days ago · 2 min read
Economic Times · 7 days ago · 2 min read
Economic Times · 12 days ago · 2 min read
Mint · 14 days ago · 2 min read
Economic Times · 16 days ago · 2 min read
Aarti Gupta coverage is leaning bullish across 11 recent stories from 3 sources. The article split is 8 bullish, 1 bearish, and 1 neutral.
The strongest article-driven stock reads in this hub are DRL (+70), MANKIND (+70), AARTIPHARM (+67). These scores are based on saved article impact, not a standalone buy signal.
No clear negative stock cluster is available for Aarti Gupta yet.
Recent Aarti Gupta coverage is clustering around Pharmaceuticals, Banking, Chemicals.